
23 Feb 2024
French specialty chemicals company Seqens has unveiled a new distribution collaboration in India with KK India Petroleum Specialties PVT Ltd for the distribution of Seqens lubricant additives.....
French specialty chemicals company Seqens has unveiled a new distribution collaboration in India with KK India Petroleum Specialties PVT Ltd for the distribution of Seqens lubricant additives.
Seqens, a global leader in specialty ingredient development and production, boasts a workforce of 3,500 spread across nine manufacturing countries. The company's diverse portfolio and advanced technologies cater to various industries, including pharmaceuticals.
Under the agreement, KK India Petroleum is designated as the authorized distributor for India, encompassing Bangladesh, Sri Lanka, and Nepal. The objective is to strengthen Seqens' global footprint in serving customers in the lubricant formulations and metalworking fluid sectors.
François Chabaud, President of Seqens Industrial Solutions, emphasized that KK India's efficient team and robust logistics network will help meet the growing demand for lubricants in the region. He also highlighted Seqens' commitment to collaborating closely with KK India to address customer formulation and troubleshooting needs.
KK India, established in Mumbai over 30 years ago, is a family-owned company engaged in importing, exporting, and distributing specialty chemicals. With a company warehouse spanning over 30,000 square feet and established relationships across sectors, KK India is well-positioned to facilitate the distribution partnership.
As an integrated player involved in the entire process from R&D to manufacturing, Seqens offers lubricant technologies such as extreme pressure additives and corrosion inhibitors. The collaborative approach of Seqens aims to assist customers worldwide in enhancing performance. The company's workforce of 3,500 is spread across nine manufacturing countries, reflecting its global presence in specialty ingredient development and production for pharmaceuticals and other specialty solutions.
Source